Literature DB >> 27556728

Pathophysiology of peripheral arterial disease in diabetes mellitus.

Shao-Ling Yang1, Lv-Yun Zhu2, Rui Han3, Lei-Lei Sun4, Jun-Xia Li5, Jing-Tao Dou1.   

Abstract

Peripheral arterial disease (PAD) increases the risk of lower extremity amputation. It is also an independent predictor of cardiovascular and cerebrovascular ischemic events, affecting both the quality and expectancy of life. Many studies have demonstrated that the prevalence of PAD in patients with diabetes mellitus (DM) is higher than in non-diabetic patients. In diabetic patients, PAD occurs early with rapid progression, and is frequently asymptomatic. Multiple metabolic aberrations in DM, such as advanced glycation end-products, low-density lipoprotein cholesterol, and abnormal oxidative stress, have been shown to worsen PAD. However, the role of DM in PAD is not completely understood. The purpose of the present article is to review and discuss the pathophysiology of PAD in DM.
© 2016 Ruijin Hospital, Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  diabetes mellitus; pathophysiology; peripheral arterial disease

Mesh:

Substances:

Year:  2016        PMID: 27556728     DOI: 10.1111/1753-0407.12474

Source DB:  PubMed          Journal:  J Diabetes        ISSN: 1753-0407            Impact factor:   4.006


  22 in total

Review 1.  Expatiating the molecular approaches of HMGB1 in diabetes mellitus: Highlighting signalling pathways via RAGE and TLRs.

Authors:  Tapan Behl; Eshita Sharma; Aayush Sehgal; Ishnoor Kaur; Arun Kumar; Rashmi Arora; Giridhari Pal; Munish Kakkar; Ravinder Kumar; Simona Bungau
Journal:  Mol Biol Rep       Date:  2021-01-21       Impact factor: 2.316

2.  Associations between bone mineral density and subclinical peripheral arterial disease in elderly men with type 2 diabetes mellitus.

Authors:  X Zhang; Y Xu; F Li; M Chen
Journal:  Osteoporos Int       Date:  2022-04-22       Impact factor: 5.071

Review 3.  The Contribution of Wnt Signaling to Vascular Complications in Type 2 Diabetes Mellitus.

Authors:  Raquel Sanabria-de la Torre; Cristina García-Fontana; Sheila González-Salvatierra; Francisco Andújar-Vera; Luis Martínez-Heredia; Beatriz García-Fontana; Manuel Muñoz-Torres
Journal:  Int J Mol Sci       Date:  2022-06-23       Impact factor: 6.208

4.  TMEM16A channel upregulation in arterial smooth muscle cells produces vasoconstriction during diabetes.

Authors:  M Dennis Leo; Dieniffer Peixoto-Nieves; Wen Yin; Somasundaram Raghavan; Padmapriya Muralidharan; Alejandro Mata-Daboin; Jonathan H Jaggar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-01-15       Impact factor: 4.733

5.  Elevated serum fibroblast growth factor 23 levels as an indicator of lower extremity atherosclerotic disease in Chinese patients with type 2 diabetes mellitus.

Authors:  Xingxing He; Xiang Hu; Xiaojing Ma; Hang Su; Lingwen Ying; Jiahui Peng; Xiaoping Pan; Yuqian Bao; Jian Zhou; Weiping Jia
Journal:  Cardiovasc Diabetol       Date:  2017-06-15       Impact factor: 9.951

6.  Role of Hyperglycemia-Induced Advanced Glycation End Product (AGE) Accumulation in Atherosclerosis.

Authors:  Sho-Ichi Yamagishi; Takanori Matsui
Journal:  Ann Vasc Dis       Date:  2018-09-25

7.  9th Asian PAD Workshop.

Authors: 
Journal:  Ann Vasc Dis       Date:  2018-09-25

8.  Imaging the Proangiogenic Effects of Cardiovascular Drugs in a Diabetic Model of Limb Ischemia.

Authors:  J L Goggi; A Haslop; R Boominathan; K Chan; V Soh; P Cheng; E G Robins; K K Bhakoo
Journal:  Contrast Media Mol Imaging       Date:  2019-02-03       Impact factor: 3.161

9.  Pretreatment of Diabetic Adipose-derived Stem Cells with mitoTEMPO Reverses their Defective Proangiogenic Function in Diabetic Mice with Critical Limb Ischemia.

Authors:  Kun Lian; Qin Wang; Shuai Zhao; Maosen Yang; Genrui Chen; Youhu Chen; Congye Li; Haokao Gao; Chengxiang Li
Journal:  Cell Transplant       Date:  2019-11-05       Impact factor: 4.064

10.  Geranylgeranyl Transferase-I Knockout Inhibits Oxidative Injury of Vascular Smooth Muscle Cells and Attenuates Diabetes-Accelerated Atherosclerosis.

Authors:  Guo-Ping Chen; Jian Yang; Guo-Feng Qian; Wei-Wei Xu; Xiao-Qin Zhang
Journal:  J Diabetes Res       Date:  2020-08-10       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.